Loading clinical trials...
Loading clinical trials...
A Randomized, Prospective, Multicenter, Double Blind, Parallel Assignment, Placebo Controlled Bioequivalence Study of Pimecrolimus Cream, 1% and Elidel® (Pimecrolimus) Cream, 1% in Patients With Mild to Moderate Atopic Dermatitis
Conditions
Interventions
Pimecrolimus Cream, 1%
Placebo Cream
+1 more
Locations
27
United States
Research Facility 6
Boynton Beach, Florida, United States
Research Facility 4
Coral Gables, Florida, United States
Research Facility 5
Miami, Florida, United States
Research Facility 10
Miami, Florida, United States
Research Facility 1
Miami Lakes, Florida, United States
Research Facility 9
Miramar, Florida, United States
Start Date
February 29, 2016
Primary Completion Date
May 15, 2017
Completion Date
May 15, 2017
Last Updated
March 7, 2022
NCT07262983
NCT06389136
NCT06342713
NCT07290803
NCT07223697
NCT07265479
Lead Sponsor
Mylan Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions